Summary
Chemogenomics is a modern approach to analysis of the biological effect of a wide array of small molecule compounds on a large set of homologous receptors or other macromolecular drug targets. However, the relative productivity of the method and the extremely high-cost procedure jointly force the scientist to use additional computational tools for rational compound library design and selection. The present chapter will focus specifically on application of a predictive mapping computational technology in the context of the fundamental principles of chemogenomic approach to foster rational drug design and derive information from the simultaneous biological evaluation of multiple compounds on a set of coherent biological targets.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Olah, M., Mracec, M., Ostopovici, L., Rad, R., Bora, A., Hadaruga, N., Olah, I., Banda, M., Simon, Z., Mracec, M., and Oprea, T. I. (2004) WOMBAT: World of molecular bioactivity. In: Oprea, T. I. (ed.) Cheminformatics in Drug Discovery. Wiley-VCH, Weinheim, pp. 223–239.
Vanco, J. (2003) The Beilstein CrossFire Information System and its use in pharmaceutical chemistry. Ceska Slov. Farm. 52, 68–72.
Ivanenkov, Y. A., Balakin, K. V., Skorenko, A. V., Tkachenko, S. E., Savchuk, N. P., Ivachtchenko, A. A., and Nikolsky Y. (2003) Application of advanced machine learning algorithm for profiling specific GPCR-active compounds. Chem. Today 21, 72–75.
Todeschini, R., Consonni, V., Mannhold, R., Kubinyi, H., and Timmerman, H. (2000) Handbook of Molecular Descriptors. Wiley, New York.
Kohonen, T. (1990) The self-organizing map. Proceedings of the IEEE 78, 1464–1480.
Anzali, S., Gasteiger, J., Holzgrabe, U., Polanski, J., Sadowski, J., Teckentrup, A., and Wagener, M. (1998) The use of self-organizing neural networks in drug design. In: Kubinyi, H., Folkers, G., and Martin, Y. C. (eds.) 3D QSAR in Drug Design. Kluwer/ESCOM, Dordrecht, pp. 273–99.
Bauknecht, H., Zell, A., Bayer, H., Levi, P., Wagener, M., Sadowski, J., and Gasteiger, J. (1996) Locating biologically active compounds in medium-sized heterogeneous datasets by topological autocorrelation vectors: Dopamine and benzodiazepine agonists. J. Chem. Inf. Comput. Sci. 36, 1205–1213.
Anzali, S., Barnickel, G., Krug, M., Sadowski, J., Wagener, M., Gasteiger, J., and Polanski, J. (1996) The comparison of geometric and electronic properties of molecular surfaces by neural networks: Application to the analysis of corticosteroid binding globulin activity of steroids. J. Comput. Aided Mol. Des. 10, 521–534.
Brűstle, M., Beck, B., Schindler, T., King, W., Mitchell, T., and Clark, T. (2002) Descriptors, physical properties, and drug-likeness. J. Med. Chem. 45, 3345–3355.
Rabow, A. A., Shoemaker, R. H., Sausville, E. A., and Covell, D. G. (2002) Mining the National Cancer Institute’s tumor-screening database: Identification of compounds with similar cellular activities. J. Med. Chem. 45, 818–840.
Korolev, D., Balakin, K. V., Nikolsky, Y., Kirillov, E., Ivanenkov, Y. A., Savchuk, N. P., Ivashchenko, A. A., and Nikolskaya, T. (2003) Modeling of human cytochrome P450-mediated drug metabolism using unsupervised machine learning approach. J. Med. Chem. 46, 3631–3643.
Savchuk, N. P. (2003) In silico ADME-Tox as part of an optimization strategy. Curr. Drug Discov. 4, 17–22.
Kier, L. B., and Hall, L. H. (1986) Molecular Connectivity in Structure-Activity Analysis. Wiley, New York.
Basak, S. C., Balaban, A. T., Grunwald, G. D., and Gute, B. D. (2000) Topological indices: Their nature and mutual relatedness. J. Chem. Inf. Comput. Sci. 40, 891–898.
Bonchev, F. (2000) Overall connectivities/topological complexities: A new powerful tool for QSPR/QSAR. J. Chem. Inf. Comput. Sci. 40, 934–941.
Kubinyi, H. (1993) QSAR. Hansch Analysis and Related Approaches. In: Manhold, R., Krogsgaard-Larsen, P., and Timmermann, H. (eds.) Methods and Principles in Medicinal Chemistry, vol. 1. VCH, Weinheim, pp. 21–36.
Livingstone, D. J. (2000) The characterization of chemical structures using molecular properties. a survey. J. Chem. Inf. Comput. Sci. 40, 195–209.
Jolliffe, I. T. (1986) Principal Component Analysis. Springer-Verlag, New York.
Cooley, W., and Lohnes, P. (1971) Multivariate Data Analysis. Wiley, New York.
Clark, D. E., and Pickett, S. D. (2000) Computational methods for the prediction of ‘drug-likeness’. Drug Discov. Today 5, 49–58.
Oprea, T. I., Davis, A. M., Teague, S.J., and Leeson, P. D. (2001) Is there a difference between leads and drugs? A historical perspective. J. Chem. Inf. Comput. Sci. 41, 1308–1315.
Klabunde, T. (2006) Chemogenomic approaches to ligand design. In: Rognan, D. (ed.) Ligand Design for G-protein-Coupled Receptors. Wiley-VCH, Weinheim, pp. 115–135.
Rognan, D. (2007) Chemogenomic approaches to rational drug design. Br. J. Pharmacol. 152, 38–52.
Zlotnik, A., and Yoshie, O. (2000) Chemokines: A new classification system and their role in immunity. Immunity 12, 121–127.
Yoshie, O., Imai, T., and Nomiyama, H. (2001) Chemokines in immunity. Adv. Immunol. 78, 57–110.
Balakin, K. V., Ivanenkov, Y. A., Tkachenko, S. E., Kiselyov, A. S., and Ivachtchenko, A. V. (2008) Regulators of chemokine receptor activity as promising anticancer therapeutics. Curr. Cancer Drug Targets 8, 299–340.
Zlotnik, A., Yoshie, O., and Nomiyama, H. (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol. 7, 243.
Allavena, P., Marchesi, F., and Mantovani, A. (2005) The role of chemokines and their receptors in tumor progression and invasion: Potential new targets of biological therapy. Curr. Cancer Ther. Rev. 1, 81–92.
Pérez-Nueno, V. I., Ritchie, D. W., Rabal, O., Pascual, R., Borrell, J. I., and Teixidó, J. (2008) Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking. J. Chem. Inf. Model. 48, 509–533.
Spencer, E. H. (2005) Development of a Structure Prediction Method for G-Protein Coupled Receptors, Thesis. California Institute of Technology, Pasadena, CA.
Efremov, R., Truong, M. J., Darcissac, E. C., Zeng, J., Grau, O., Vergoten, G., Debard, C., Capron, A., and Bahr, G. M. (2001) Human chemokine receptors CCR5, CCR3 and CCR2B share common polarity motif in the first extracellular loop with other human G-protein coupled receptors. Eur. J. Biochem. 263, 746–756.
Torgerson, W. S. (1952) Multi-dimensional scaling: I. Theory and method. Psychometrika 17, 401–419.
Kruskal, J. B. (1964) Non-metric multi-dimensional scaling: A numerical method. Psychometrika 29, 115–129.
Goldberg, D. E. (1989) Genetic Algorithms in Search, Optimization, and Machine Learning. Addison-Wesley, Reading.
Bigus, J. P. (1996) Data Mining with Neural Networks. McGraw-Hill, New York.
Kubinyi, H. (1994) Variable selection in QSAR studies. I. An evolutionary algorithm. Quant. Struct.-Act. Relat. 13, 285–294.1.Lipinski, C.A., Lombardo, F., Dominy, B.W., and Feeney, P.J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Deliv. Rev. 23, 3–25.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Balakin, K.V., Ivanenkov, Y.A., Savchuk, N.P. (2009). Compound Library Design for Target Families. In: Jacoby, E. (eds) Chemogenomics. Methods in Molecular Biology, vol 575. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-274-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-60761-274-2_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-273-5
Online ISBN: 978-1-60761-274-2
eBook Packages: Springer Protocols